Mental Health Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Mental Health Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
University of California, Los Angeles
Tumor immunology and targeted immunotherapy for CNS malignancies are reviewed
December 17th, 2005
Scientists review tumor immunology and targeted immunotherapy for central nervous system malignancies in a recent issue of the journal Neurological Research. According to a study from the United States, "Although the brain was traditionally considered as 'immunologically privileged', recent findings have implied an involvement of immune mechanisms in neurological disease and illness, including central nervous system (CNS) malignancies. In [our] review, we initially focus on aspects of the immune system critical for effective antitumor immunity, as an understanding of normal immunological functions and how they relate to tumor immunology will set a foundation for...
Source: Mental Health Law Weekly (2005-12-17)
|
